UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
UC San Diego’s Entrepreneurs-in-Residence program, which currently features three savvy business professionals who help advise students on start-up ideas, has gained two additional experts.
When astronaut Scott Kelly returns to Earth on March 1, half of NASA’s first-of-its-kind study of twin astronauts and long duration space flight, researchers at University of California, San Diego School of Medicine and elsewhere will launch the mission’s next phase.
Ten teams of innovative students at UC San Diego have been awarded proof-of-concept funding to validate the product concepts behind their innovative projects.
Scripps Institution of Oceanography at UC San Diego Distinguished Professor William Gerwick received the American Society of Pharmacognosy’s Norman R. Farnsworth Research Achievement Award for his outstanding contributions to natural products research. Gerwick will accept the award during the Society’s annual meeting in July at the 2016 Joint Natural Products Conference in Copenhagen.
As a public research university, UC San Diego is committed to the highest standards of integrity in research.
Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego School of Medicine has launched a new NAFLD Research Center to better understand the disease and develop treatments where none currently exist.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
